Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Legend Biotech (LEGN) and Intuitive Surgical (ISRG)
Buy Rating Affirmed for Legend Biotech Amid Promising Carvykti Trial Results and Expert Endorsements
Buy Rating on Legend Biotech: CARVYKTI's Clinical Success and Expanding Manufacturing Capacity
Scotiabank Keeps Their Buy Rating on Legend Biotech (LEGN)
Legend Biotech Analyst Ratings
Legend Biotech Analyst Ratings
Legend Biotech Analyst Ratings
Legend Biotech Analyst Ratings
Legend Biotech Analyst Ratings
Jefferies Issues a Buy Rating on Legend Biotech (LEGN)
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Merus (MRUS) and Agilon Health (AGL)
Legend Biotech Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Singular Genomics Systems (OMIC)
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Green Thumb Industries (OtherGTBIF) and OmniAb (OABI)
Scotiabank Sticks to Their Buy Rating for Legend Biotech (LEGN)
Buy Rating for Legend Biotech Anchored by Carvykti's Growth and Market Penetration Potential
Legend Biotech Analyst Ratings
RBC Adjusts Price Target on Legend Biotech to $86 From $85 on Model Updates, Maintains Outperform Rating
Analysts Are Bullish on Top Healthcare Stocks: Legend Biotech (LEGN), Oculis Holding (OCS)
Buy Rating Affirmed for Legend Biotech on CARVYKTI Growth and Positive Clinical Developments